Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males

A Phase II Randomised, Two-Way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered-Dose (MD) Lotion Doses in Hypogonadal Male Subjects

Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will evaluate the efficacy and safety of this product.

Inclusion Criteria:

• Hypogonadal males between 18-70 years old with qualifying general medical health

Exclusion Criteria:

• Disqualifying concurrent conditions or allergy/sensitivity to testosterone replacement therapy